Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
sharewise is moving On the weekend of 22/23 August the new sharewise becomes the main site. Have a look now and tell us what you miss. Go to the new sharewise What changes
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Ionis Pharmaceuticals Inc. buy BMO Capital Markets

Ionis Pharmaceuticals Inc.
Start price
€51.62
03.09.25 / 50%
Target price
€60.18
03.09.26
Performance (%)
-2.56%
Price
€50.30
20.08.26
Summary
This prediction is currently active. With a performance of -2.56%, the BUY prediction for Ionis Pharmaceuticals Inc. by BMO_Capital_Markets is down slightly. This prediction currently runs until 03.09.26. The prediction end date can be changed by BMO_Capital_Markets at any time. BMO_Capital_Markets has 50% into this prediction
Performance without dividends (%)
Name 1w 1m
Ionis Pharmaceuticals Inc. 3.797% 3.797%
iShares Core DAX® -1.586% 5.028%
iShares Nasdaq 100 -4.148% -0.125%
iShares Nikkei 225® -6.302% 0.528%
iShares S&P 500 -3.225% 0.470%

Comments by BMO_Capital_Markets for this prediction

In the thread Ionis Pharmaceuticals Inc. diskutieren
Prediction Buy
Perf. (%) -2.56%
Target price 60.179
Change
Ends at 03.09.26

Ionis Pharmaceuticals (NASDAQ:IONS) was upgraded by analysts at BMO Capital Markets from a "market perform" rating to an "outperform" rating. They now have a $70.00 price target on the stock.
Ratings data for IONS provided by MarketBeat

BMO Capital Markets 
0
Report Share
03.09.25